Sunshine Lake Pharma Co., Ltd. has proposed a merger by absorption with Yichang HEC Changjiang Pharmaceutical Co., Ltd. This transaction involves Sunshine Lake Pharma acquiring Yichang HEC Changjiang Pharmaceutical, with a proposal to withdraw the latter's listing. The announcement was made jointly by Sunshine Lake Pharma and Yichang HEC Changjiang Pharmaceutical. The companies have released a composite document detailing the transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on June 29, 2025, and is solely responsible for the information contained therein.